J Ovarian Res. 2012 Nov 07;5(1):32. doi: 10.1186/1757-2215-5-32.
Gonadotropin treatment augments postnatal oogenesis and primordial follicle assembly in adult mouse ovaries?.
Journal of ovarian research
Deepa Bhartiya, Kalpana Sriraman, Pranesh Gunjal, Harshada Modak
Affiliations
Affiliations
- Stem Cell Biology Department, National Institute for Research in Reproductive Health, Mumbai, 400 012, India. [email protected].
PMID: 23134576
PMCID: PMC3616927 DOI: 10.1186/1757-2215-5-32
Abstract
BACKGROUND: Follicle stimulating hormone (FSH) exerts action on both germline and somatic compartment in both ovary and testis although FSH receptors (FSHR) are localized only on the somatic cells namely granulosa cells of growing follicles and Sertoli cells in the seminiferous tubules. High levels of FSH in females are associated with poor ovarian reserve, ovarian hyper stimulation syndrome etc. and at the same time FSH acts as a survival factor during in vitro organotypic culture of ovarian cortical strips. Thus a further understanding of FSH action on the ovary is essential. We have earlier reported presence of pluripotent very small embryonic-like stem cells (VSELs express Oct-4A in addition to other pluripotent markers) and their immediate descendants 'progenitors' ovarian germ stem cells (OGSCs express Oct-4B in addition to other germ cell markers) in ovarian surface epithelium (OSE) in various mammalian species including mice, rabbit, monkey, sheep and human. Present study was undertaken to investigate the effect of pregnant mare serum gonadotropin (PMSG) on adult mice ovaries with a focus on VSELs, OGSCs, postnatal oogenesis and primordial follicle assembly.
METHODS: Ovaries were collected from adult mice during different stages of estrus cycle and after 2 and 7 days of PMSG (5 IU) treatment to study histo-architecture and expression for FSHR, pluripotent stem cells , meiosis and germ cell specific markers.
RESULTS: PMSG treatment resulted in increased FSHR and proliferation as indicated by increased FSHR and PCNA immunostaining in OSE and oocytes of primordial follicles (PF) besides the granulosa cells of large antral follicles. Small 1-2 regions of multilayered OSE invariably associated with a cohort of PF during estrus stage in control ovary were increased to 5-8 regions after PMSG treatment. This was associated with an increase in pluripotent transcripts (Oct-4A, Nanog), meiosis (Scp-3) and germ cells (Oct-4B, Mvh) specific markers. MVH showed positive immuno staining on germ cell nest-like clusters and at places primordial follicles appeared connected through oocytes.
CONCLUSIONS: The results of the present study show that gonadotropin (PMSG) treatment to adult mouse leads to increased pluripotent stem cell activity in the ovaries, associated with increased meiosis, appearance of several cohorts of PF and their assembly in close proximity of OSE. This was found associated with the presence of germ cell nests and cytoplasmic continuity of oocytes in PF. We have earlier reported that pluripotent ovarian stem cells in the adult mammalian ovary are the VSELs which give rise to slightly differentiated OGSCs. Thus we propose that gonadotropin through its action on pluripotent VSELs augments neo-oogenesis and PF assembly in adult mouse ovaries.
References
- Endocr Relat Cancer. 2006 Jun;13(2):641-51 - PubMed
- Hum Reprod. 1999 Jun;14(6):1555-62 - PubMed
- Stem Cells Dev. 2012 Jan;21(1):1-6 - PubMed
- Mol Cell Biol Res Commun. 1999 Jul;2(1):21-7 - PubMed
- Aging (Albany NY). 2009 Dec 12;1(12):971-8 - PubMed
- Endocrinology. 2006 May;147(5):2338-45 - PubMed
- Endocrinology. 2001 Jan;142(1):381-9 - PubMed
- Mech Dev. 2000 May;93(1-2):139-49 - PubMed
- Ann N Y Acad Sci. 2010 Sep;1205:5-11 - PubMed
- Nature. 2004 Mar 11;428(6979):145-50 - PubMed
- Mol Hum Reprod. 2006 May;12(5):283-9 - PubMed
- Mol Cell Endocrinol. 2001 Feb 14;172(1-2):213-22 - PubMed
- Nat Med. 2012 Feb 26;18(3):413-21 - PubMed
- Dev Biol. 2003 Oct 15;262(2):303-12 - PubMed
- Differentiation. 2010 Mar;79(3):159-70 - PubMed
- Fertil Steril. 2009 May;91(5 Suppl):1967-75 - PubMed
- Reprod Biomed Online. 2004 Apr;8(4):385-91 - PubMed
- Int J Cancer. 2004 Dec 10;112(5):803-14 - PubMed
- Anat Rec (Hoboken). 2011 Aug;294(8):1284-306 - PubMed
- Cancer Res. 2001 Sep 15;61(18):6768-76 - PubMed
- Biol Reprod. 2012 Jul 05;87(1):3, 1-11 - PubMed
- J Clin Endocrinol Metab. 2000 Jan;85(1):270-4 - PubMed
- Reproduction. 2001 Mar;121(3):455-61 - PubMed
- J Clin Endocrinol Metab. 2002 May;87(5):2245-53 - PubMed
- Biol Reprod. 2004 Nov;71(5):1501-7 - PubMed
- Reprod Sci. 2013 Jan;20(1):7-15 - PubMed
- Oncol Res. 2008;17(5):231-8 - PubMed
- Differentiation. 2008 Oct;76(8):843-56 - PubMed
- Hum Reprod. 2012 Mar;27(3):938; author reply 938-9 - PubMed
- Biol Reprod. 1994 Nov;51(5):821-30 - PubMed
- Stem Cells Dev. 2011 Aug;20(8):1451-64 - PubMed
- Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12580-5 - PubMed
- Cytometry A. 2009 Jan;75(1):4-13 - PubMed
- Curr Biol. 2003 Dec 2;13(23):2110-7 - PubMed
- BMC Dev Biol. 2003 Mar 19;3:1 - PubMed
- Clin Cancer Res. 2000 Jul;6(7):2764-70 - PubMed
- Reprod Biol Endocrinol. 2004 Apr 28;2:20 - PubMed
- Stem Cells Dev. 2012 Mar 20;21(5):670-4 - PubMed
- Am J Pathol. 1996 Jan;148(1):47-53 - PubMed
- Curr Pharm Des. 2012;18(3):283-92 - PubMed
- Gene Expr Patterns. 2005 Jun;5(5):639-46 - PubMed
- Endocrinology. 1979 Oct;105(4):960-6 - PubMed
- Am J Pathol. 2009 Jun;174(6):1985-92 - PubMed
- Endocrinology. 2000 Dec;141(12):4449-56 - PubMed
- Int J Cancer. 2003 Jan 20;103(3):328-34 - PubMed
- Mol Cell Endocrinol. 2007 Jan 2;260-262:163-71 - PubMed
- Hum Reprod. 2011 Aug;26(8):2129-39 - PubMed
- J Clin Endocrinol Metab. 2002 May;87(5):2266-76 - PubMed
- Reproduction. 2012 Feb;143(2):139-49 - PubMed
- Stem Cell Rev Rep. 2010 Jun;6(2):307-16 - PubMed
- J Cell Physiol. 2004 Jan;198(1):119-24 - PubMed
- Genome Biol. 2000;1(3):REVIEWS1017 - PubMed
- Mol Cell Endocrinol. 2007 Mar 15;267(1-2):26-37 - PubMed
- J Reprod Immunol. 2007 Jun;74(1-2):24-33 - PubMed
- Int J Gynecol Pathol. 2005 Apr;24(2):153-63 - PubMed
- Gynecol Endocrinol. 1999 Apr;13(2):75-81 - PubMed
- Mol Cell Endocrinol. 2001 Apr 25;175(1-2):29-39 - PubMed
- Reproduction. 2006 Jul;132(1):95-109 - PubMed
- J Reprod Fertil. 1986 May;77(1):287-96 - PubMed
- Reprod Sci. 2008 Feb;15(2):139-46 - PubMed
- Biol Reprod. 2010 Jan;82(1):13-22 - PubMed
- Endocr Rev. 2007 Jun;28(4):440-61 - PubMed
- J Clin Endocrinol Metab. 2004 Nov;89(11):5508-16 - PubMed
- J Histochem Cytochem. 2010 Dec;58(12):1093-106 - PubMed
- Chromosome Res. 2004;12(3):197-213 - PubMed
- Obstet Gynecol Int. 2012;2012:921082 - PubMed
- Hum Reprod Update. 1997 May-Jun;3(3):281-95 - PubMed
- J Biol Chem. 2006 Nov 3;281(44):33554-65 - PubMed
- Nat Med. 2012 Mar 06;18(3):353-4 - PubMed
- Endocr Rev. 2009 Aug;30(5):465-93 - PubMed
- Hum Reprod. 1986 Feb;1(2):81-7 - PubMed
- Cell Cycle. 2008 Mar 1;7(5):683-6 - PubMed
- Nat Cell Biol. 2009 May;11(5):631-6 - PubMed
- Biol Reprod. 2012 Oct 04;87(4):80 - PubMed
Publication Types